chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pink blotch spreading on her arm; Lump around injection site; Red blotch around injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MACULAR (Pink blotch spreading on her arm), LIPOHYPERTROPHY (Lump around injection site) and VACCINATION SITE ERYTHEMA (Red blotch around injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 080A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced LIPOHYPERTROPHY (Lump around injection site) and VACCINATION SITE ERYTHEMA (Red blotch around injection site). On 11-Mar-2021, the patient experienced RASH MACULAR (Pink blotch spreading on her arm). On 11-Mar-2021, LIPOHYPERTROPHY (Lump around injection site) had resolved. At the time of the report, RASH MACULAR (Pink blotch spreading on her arm) and VACCINATION SITE ERYTHEMA (Red blotch around injection site) outcome was unknown.            Treatment included Tylenol on 10-Mar-2021. concomitant medications not provided.
2 days p/vax itchy rash-skin red & blotchy over neck, arms legs & torso w/tiny papules noted per mom;tx w/DPh relief of rash & itching;
Low grade fever; Chills; Runny nose; Body aches; Not feeling well right now; voice not clear; This is a spontaneous report from a contactable consumer (patient). An unspecified age and unspecified gender of patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on 02Aug2021as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and the patient's concomitant medications were not reported. In 2021 the patient had experienced low grade fever, chills, runny nose, body aches, not feeling well and things that (voice not clear). The reporter wanted to know how long these side effects are going to last. The outcome of the events were not recovered.  QR Comment: Reporter type could not be probed as the consumer was unwilling to share any further information, hence captured by default as Consumer or other non-health professional in tab.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.  Follow Up (26Aug2021): No follow-up attempts are possible; information about lot/batch number cannot be obtained.
weird taste in mouth, extremely tired, without energy, heartbeat going up, nauseated, feel swelling in face, pressure, heaviness and feeling flushed; weird taste in mouth, extremely tired, without energy, heartbeat going up, nauseated, feel swelling in face, pressure, heaviness and feeling flushed; weird taste in mouth, extremely tired, without energy, heartbeat going up, nauseated, feel swelling in face, pressure, heaviness and feeling flushed; weird taste in mouth, extremely tired, without energy, heartbeat going up, nauseated, feel swelling in face, pressure, heaviness and feeling flushed; weird taste in mouth, extremely tired, without energy, heartbeat going up, nauseated, feel swelling in face, pressure, heaviness and feeling flushed; walked around for 15 minutes and just felt like a heaviness; anxiety; have like a fruity taste in the mouth, not fruity but just some taste lingering in the mouth; feeling flushed; feel swelling in face; dizzy; This is a spontaneous report from a contactable consumer (Reported for herself). A 42-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization at grocery store. The patient's medical history and concomitant medications were not reported. The consumer stated that she walked around the store for about half an hour and was okay but when she started driving home, she started experiencing side effects such as weird taste in mouth, extremely tired, without energy, heartbeat going up, nauseated, feel swelling in face, pressure, heaviness and feeling flushed. When she drank water, she noticed like a fruity taste in the mouth, not fruity but just some taste lingering in the mouth. She knew her heart rate went up because she saw her Heart rate go up on her exercise watch. Report was not related to a study or programme. The patient underwent lab tests and procedures which included heart rate: increased on an unspecified date. She wanted to know if all of this was normal. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
APPROX 12 HOURS AFTER 2ND SHOT, AT 1 IN THE MORNING, WOKE UP GASPING, THEN WENT FOR APPROX 8 HOURS CONTINUOUSLY GASPING AT EVERY BREATH, SHORT AND QUICK BREATHS.  SEEMED LIKE I NEVER FEEL ASLEEP UNTIL GASPING SUBSIDED AT BOUT 7 THE NEXT MORNING.  TWO DAYS LATER STILL ACHY AND LIGHT HEADED.
This spontaneous report was received from a register nurse concerning a current 15 year old female patient with acne, who on 12-JUL-2010 was vaccinated with the first dose of GARDASIL, intramuscular, (lot # 666162/056Z). No other co-suspects were reported. Concomitant medications included minocycline. On 12-JUL-2010 the patient experienced fever, 1 day after onset of therapy, decrease energy, rash on the torso, forearms, and upper thigh, headache and right eye drooping. The patient was referred to an unspecified ophthalmologist who recorded a normal eye exam on 19-JUL-2010. On 19-JUL-2010, the patient recovered completely from the events. She had never received any other injections of GARDASIL. Additional information has been requested.
Admitted to hospital 7/3/22 was admitted with fever.  He had covid.  He was seen by ID,  He was treated with remdesivir.
My arm was in extreme pain for many months after first injection. I had a hard time using it and lifting. I kept thinking that the pain would go away but after it did not subside, I eventually went and saw an orthopedist who did X-rays and eventually an mri. His findings were that the vaccine had triggered inflammation in my arm and the inflammation was rubbing on bone spurs. He injected me with the steroid injection which helped the inflammation. I still have pain in my left arm from where I was vaccinated the first time but at least my arm is usable.
"reacting" to the first dose of the COVID-19 vaccine/ had an "assessment by an Allergist"; Swollen tongue; swollen upper lip; Sore throat; Headache; Taste metallic; Breathing moderately compromised; This is a spontaneous report from a contactable consumer or other non hcp. A 68-years-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Formulation: Solution for injection, Lot number was not reported, Batch/Lot Number was EL1283), via an unspecified route of administration, administered in Arm Left on 22Jan2021 14:00 as single dose for an COVID-19 immunization. Patient Age at Time of Vaccination was 68 years. No prior vaccination within 4 weeks other than Pfizer vaccine. The patient medical history and concomitant was not reported. Reporter stated that she did have an adverse event after receiving the Pfizer vaccine last Friday. Patient stated that twelve hours later (after vaccination) On 23Jan2021 she awoke in the night at 02:00AM with a swollen tongue and swollen upper lip, and her breathing moderately compromised. States she has been to an allergic who recommended she not take the second shot. She wants to take the second shot and that is why she is called today, to ask if she could take it. Adds a headache was what actually woke her up at 02:00AM in the morning and she also noticed a metallic taste in her mouth followed by a sore throat that lasted several days. She is scheduled for the second dose On 09Feb2021 at 14:30 the patient experienced "reacting" to the first dose of the covid-19 vaccine/ had an "assessment by an allergist on an unspecified date with outcome of unknown. The outcome of the events swollen tongue, swollen upper lip, headache and breathing moderately compromised was recovered on 23Jan2021, Sore throat recovered on 27Jan2021, taste metallic was not recovered.   Follow-up (28Jan2021): This is a follow-up spontaneous report from a contactable consumer. This consumer (patient) reported information was added.  Follow-up attempts are completed. No further information is expected.
I received the intranasal vaccine in the morning on 10/06/2015.  I knew it was a live virus, at administration the vaccine burned the inside of my nose.  And by 10 pm in the evening a ILI illness began with a small amount of congestion and malaise.  This continued through the night and by the next morning I had a full on ILI.  Intense malaise, mild fever, congestion, watery eyes and sore throat.  Symptoms continued to worsen through 10/07/2015 and progressed to headache, sore throat, and cough.  There is no chest congestion by the post nasal drainage has resulted in intense coughing.  At the time of this report, on the am of 10/09/2015, my symptoms of ILI have only gotten more intense fatigue, joint aches, headache, sore throat, mild fever and cough.  I know this is a live virus vaccine and my reaction to virus is beginning to feel like full on Influenza.  I have had the intranasal vaccine 3 times prior while in the military and not had this robust and lingering a reaction.  I know the vaccine was maintained and administered correctly, but I wanted to submit a VAERS report.
This spontaneous report as received from a physician refers to a 12 year old male patient with attention deficit/hyperactivity disorder (ADHD). The patient had no drug reactions or allergies. On an unknown date (at the age of 1 year old), the patient was vaccinated with the first dose of VARIVAX (Merck) (dose, route of administration, lot number and expiration date were not reported). On an unknown date (at the age of 5 year old), the patient received a second dose of VARIVAX (Merck) (dose, route of administration, lot number and expiration date were not reported). It was stated that the patient had no exposure to anyone else. Concomitant therapy included unspecified ADHD medications. On an unknown date, the patient presented to unspecified urgent care/emergency room with knee and hip pain with difficulty weight bearing. The physician stated that there were some diagnostic tests (unspecified) completed (results were not provided) and the patient was treated with gabapentin for severe pain. Later, on an unknown date, the patient developed a rash and shingles on left lower leg and back. The patient was placed on valacyclovir hydrochloride and was doing better a couple of days later and lesions started to crust. The polymerase chain reaction (PCR) testing was completed and showed positive for varicella zoster virus (VZV). The sample was sent to another doctor for genotyping but it leaked in transit so a second attempt was being made. The outcome of weight bearing difficulty, knee and hip pain and severe pain was unknown. The outcome of varicella zoster virus infection was recovering/resolving. The relatedness between the events and VARIVAX (Merck) was not reported. Additional information has been requested.
Friday January 21, I got my booster and Saturday I woke up feeling nauseous and fatigued. Sunday, I started running a fever and was unable to get out of bed. I went to urgent care and was tested for COVID and influenza. On Monday the 24th, I was still having issues and the doctor had me to go back in to be tested again which was also negative. I am currently still running a fever and still fatigued. I was advised to isolate in the case it is a breakthrough.
Made me sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Made me sick".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pleuritic pain in left portion of chest and back.  Pain is located in the lower anterior chest and left back.  Pain is worse with deep breaths.  Patient is treated with ketorolac, morphine, and ondansetron.
9 YEAR OLD GIVEN PFIZER COVID VACCINE FOR 12 YEARS AND OLDER
Patient became sluggish and slurred speech after 15 min post imz. We immediately layed her down and elevated her feet. We called 911 and took her BP. Her pulse and BP was elevated. EMS got to the scene and took over.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age. The patients' pertinent medical history, drug reactions/allergies and concomitant medications were not reported. The patient was vaccinated with improperly stored ROTATEQ (lot # L008054 and expiry date 30-NOV-2016) on an unknown date after 20-JUL-2016. Excursion was at temperature of 48.7 F for 5 minutes. No previous temperature excursion was noted. The call was due to digital data logger. No adverse effects reported. This is one of the two reports received from the same reporter. Additional information has been requested.
no further ae reported; Temp excursion occurred on 11/22/21; This spontaneous report was received from a nurse and refers to patients of unknown age and gender.  The patients' medical history was not reported. The patients' concurrent conditions were not reported. Concomitant therapies were not reported.  On unknown dates, the patients were vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U010398 (determined to be valid), expiration date: 01-APR-2023, administered for prophylaxis (strength, and route of administration were not provided) (administration of 17 doses was reported).  The vaccine underwent temperature excursion on an unknown date (6 degrees of Fahrenheit (F) to 14F for 10 minutes; 14F to to 46F (23.9F) for 3 hours. There was no previous temperature excursion reported. No adverse event was reported.   Follow-up information has been received from a nurse on 28-JAN-2022.  The case concerned a 51 years old, male patient.  The nurse reported that a temperature excursion occurred on 22-NOV-2021 and on 21-DEC-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously in the left arm (lot U010398, expiration date 01-APR-2023) (strength and dose were not provided), measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously in the right arm (lot T034389, expiration date 08-OCT-2022) (strength and dose were not provided) and diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) intramuscularly (lot C5787AA, expiration date 01-OCT-2022) (strength, dose and anatomical location were not provided)  No adverse event.  This is one of several reports received from the same reporter.
Shaky. No other symptoms. Symptoms resolved without treatment. Lasted <60 minutes.
Patient reports hives on torso and face occuring 5 days after receiving 2nd dose of covid vaccine. No other sx reported.
none. Covid vaccine expired. 10/25/2022. Given 01/16/2023
Patient said that she started feeling bad on Friday (day of vaccine) afternoon. She was chilling as well. Saturday morning, she started developing a rash across her entire body. Three days later, the rash was still existing and she called her doctor.
This is a spontaneous report received from contactable other-HCP, via a Pfizer-sponsored program (060820). A 66-year-old female patient received the 3rd (booster) dose of BNT162B2 (Comirnaty, batch/lot# unknown), at the age of 66, on Nov 29, 2021, single dose, for COVID-19 immunisation. The patient's medical history not reported. Concomitant medication included ibrance taken for breast cancer, start date: Nov 17, 2021 (ongoing). Vaccination history included the 1st and 2nd dose of the COVID-19 vaccine (manufacturer unknown), for COVID-19 immunization. The following information experienced lethargy/became lethargic, onset Nov 29, 2021, with outcome of recovering. Additional information: Patient takes ibrance for 21 days on, 7 off. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information  expected.
pt recvd vax;w/in 5 min of vax fell to the floor,shaking,eyes open but no LOC;tx w/ O2;given crackers & water;w/in 15min,asymptomatic;md believes event was a vasovagal episode;referred to neurologist because parent suspects sz;
rapid heart rate ranging between 100-130; extreme fatigue; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A  48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 11Mar2021 at 11:15  (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included electrocauterization and heart disorder; the patient reported that she had an electrocauterization in 1990 for a heart defect. She last saw a cardiologist in Jan2020 and all was good with her heart. But with this history, She was very concerned with her high heart rate. Concomitant medications included magnesium (MANUFACTURER UNKNOWN) from unknown date for unknown indication and multivitamins from unknown date for unknown indication. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021 at 10:00, the patient experienced rapid heart rate ranging between 100-130, extreme fatigue and joint pain. On an unknown date, the patient underwent heart rate test and the result was heart rate ranging between 100-130. The patient reported that she experienced rapid heart rate ranging between 100-130. This lasted for four hours. For two weeks, she experienced extreme fatigue and joint pain. she emailed her doctor to see if she should get her second dose, and doctor did not respond. She opted not to get her second dose and now she was wondering what her options are. therapeutic measures taken were unknown. The clinical outcome of the event rapid heart rate ranging between 100-130 resolved on 12Mar2021 and that of extreme fatigue and joint pain was resolved on 26Mar2021.  No follow-up attempts are needed. No further information is expected.
Pt received HPV vaccine in the AM and had onset of headache, nausea, vomiting, diarrhea, chills, fever, body aches, back pain, and a rash at 1100 on the same day. Pt started having diarrhea first at symptom onset and thought they had eaten something very bad. Pt then felt very cold and shivering at 1530. Reported to ED for management of symptoms and was discharged home after being stable during observation.
pt recvd vax;rash rt upper arm; T of 101; warmth at site; lt arm itches;
This spontaneous case reported by a nurse, describes the occurrence of administered expired product (318 patients received dose from vials beyond 30-day use by date) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 037C21A) for COVID-19 vaccination. No medical history reported. On Jun 18, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 18, 2021, patient administered expired product (318 patients received dose from vials beyond 30-day use by date). On Jun 18, 2021, administered expired product (318 patients received dose from vials beyond 30-day use by date) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information.
9:00 AM appt. Parent called & said that patient felt dizzy & like he was going to pass out. She called MD and patient rested at home. Phone call made the next day to check on him & states he was ok.
Day 1 after vaccination sight of injection sore and entire body felt sore as well as fatigued.  Day 2 woke up feeling fine other than fatigued and developed chills later in the day.  Both days have I have felt exhausted after trying to complete a physical task such as cleaning out the car or pulling up weeds.
Patient called 2/5/18 to report that she had redness, swelling, and itching on inner aspect of vaccine arm from armpit to elbow. Reaction began day after vaccine received and lasted for 3 days then resolved. Patient did take antihistamine. No breathing troubles reported.
pt recv vax; devel rash at site of TB tine test as well as site of measles,mumps & rubella virus vax; felt to be a papular dermatitis; recovered;
Resident was admitted to facility on January 7th. Residents 3008 revealed that resident had not received any doses of the Covid-19 vaccine at healthcare facility. On 1/7/21 ICP spoke with both the Resident and spouse Regarding his vaccinations ( Covid-19, Flu and Pneumonia.) Both stated that resident had not yet received the Covid-19 vaccine and he would like to . Consent given .On 1/11/21 resident received a Covid-19 vaccine by Pharmacist. On 1/21/21 Our business office manager, received a letter in the mail from healthcare facility. Inside the envelope was a triplicate form stating that the resident did in fact receive the first dose of the Covid-19 vaccine on 1/5/21 at healthcare facility. ICP contacted pharmacy to find out how this could of happened. Pharmacy could not explain how it happened. Document has been scanned into our computer system and resident has had no adverse reaction from obtaining 2 doses of the Covid-19 vaccine @ 6 days apart.
On June 1, 2021 at approximately 1500 hours, patient received the Pfizer-BioNTech) vaccination. At approximately 1517 hours, the attendee abruptly left the observation area quickly moving toward the restroom. Registered Nurse observed this reaction and immediately followed behind the attendee to the restroom. The attendee vomitted a small amount of fluid at this time and was escorted back to the observation area. At approximately 1520 hours, vitals signs were taken with the result of BP:128/78, HR 90, SPO2 99, Temp 97.9. At approximately 1525 hours, the attendee reported an itchy sensation on the left side of her throat and subjective symptoms dizziness and warmth. The attendee was administered 50 mg of Benadryl at this time and instant ice packs were applied to the back of the neck. Symptoms resolved within minutes and the patient was released home with instructions about adverse effects and when to seek medical attention.
Pt had full body rash, rash was red and raised at site of injection, their was a dime sized blister with a quarter sized area of redness around blister. Treatment: Prednisone for 10 days and Claritin for 10 days. No fever and no itchiness.
Red, itchy, swollen with a lump  starting February 17-18 approximately 2 inches by 1 inch.
Patient given first dose 5/28/2021 and second dose given 6/6/2021; no complications and patient was notified